期刊文献+

促凝因子在急性冠脉综合征预后中的作用 被引量:3

Roles of thrombogenic mediators in the prognosis of acute coronary syndromes
下载PDF
导出
摘要 目的:研究纤维蛋白原(FIB)、纤溶酶原激活剂抑制物-1(PAI-1)、血管假性血友病因子(vonWillebrand因子,vWF)、血栓素A2(TXA2)、前列腺环素(PGI2)等促凝因子在急性冠脉综合征(ACS)患者预后中的作用。方法:连续观察76例ACS患者入院时上述指标的变化,随访3~7个月,记录住院期间和出院后新发生的心血管事件。结果:ACS患者血浆中FIB、PAI-1、vWF、TXB2浓度明显高于正常对照。随访期内发生心血管事件者FIB和vWF浓度高于未发生者;多因素logistic回归分析显示FIB和vWF是心血管事件的独立危险因素。结论:FIB、PAI-1、vWF、TXA2参与ACS发病机制。FIB和vWF影响ACS患者短期预后。 Objective:To study the predictive value in cardiac events of ACS patients of thrombogenic mediators such as fibrinogen,plasminogen activator inhibitor type-1(PAI-1),von Willebrand factor(vWF),thromboxane A 2 (TXA 2 )and prostacycline(PGI 2 ).Methods:Continuously observed76cases of ACS patients,and followed for3~7months.Results:Concentrations of fibrinogen,PAI-1,vWF and TXB 2 were significantly raised compared with the normal controls.Those who developed cardiac events had higher fibrinogen and vWF levels than those who survived free.Multivariate logistic regression analysis demonstrated fibrinogen and vWF were independent risk factors.Conclusions:Fibrinogen,PAI-1,vWF and TXA 2 played roles in the pathogenesis of ACS.Fibrinogen and vWF had influence on the prognosis of ACS patients in short follow-up period.
出处 《山东大学学报(医学版)》 CAS 2003年第3期271-274,共4页 Journal of Shandong University:Health Sciences
关键词 急性冠脉综合征 促凝因子 预后 Acute coronary syndrome Thrombogenic mediator Prognosis
  • 相关文献

参考文献6

  • 1Braundwald E. Unstable angina: a classification[J]. Circulation, 1989, 80:410.
  • 2Normenclature and criteria for diagnosis of ischemic heart disease.Report of the Joint International Society and Federation of Cardiology/World Health Organization Task force on Standardization of clinical nomenclature[J], circulation, 1979, 59:667.
  • 3Vander Wal AC, Beeker AE, van der Loos CM, et al.Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology[J]. Cireulation,1994, 89:36.
  • 4Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes[J]. Am J Cardiol ,2001, 88(suppl): 10k.
  • 5Holmvang L, Clemmensen P, Wagner G. Admission standard electrocardiogram for early risk stratification in patients with unstable coronary artery disease not eligible for acute revascularization therapy: a TRIM substudy.ThRombin Inhibition in myocardial infarction[J]. Am Heart J ,1999, 137(1) :24.
  • 6Lindahl B,Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long term mortality in unstable coronary artery disease[J]. N Eng J Med, 2000, 343(16):1139.

同被引文献23

  • 1赵京林,杨跃进,吴永建,荆志成,尤士杰,杨伟宪,孟亮,田毅,陈纪林,高润林,陈在嘉.抗血小板药物对猪急性心肌梗死再灌注后无再流的影响[J].中华医学杂志,2005,85(31):2187-2191. 被引量:20
  • 2路亚枫,胡大一,翟艳苓.急性心肌梗死患者直接PCI前后血浆TF、TFPI水平的变化及其临床意义[J].首都医科大学学报,2005,26(4):457-459. 被引量:5
  • 3Channon K. Oxidative stress and coronary plaque stability[J]. Arterioscler Thromb Vasc Biol, 2002, 22(11 ) : 1751-1752.
  • 4Elmouchi D A, Bates E R. Platelet glycoprotein Ⅱb/Ⅲa inhibitor therapy in st-segment elevation acute coronary syndromes [J]. Mineva Cardioangiol, 2003, 51(5):547-560.
  • 5Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction[J].J Am Coll Cardiol, 1999, 33(3) :654-660.
  • 6Heitzer T, Schlinzig T, Krohn K, et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease[J]. Circulation, 2001, 104(22):2673-2678.
  • 7Nogan G, John F K, Liza M H, et al. Risk stratification for postoperation cardiovascular events via noninvasive assessment of endothelial function[J]. Circulation, 2002, 105(13) :1567-1572.
  • 8Sakai H, Goto S, Kim J Y, et al. Plasma concentration of yon Willebrand factor in acute myocardial infarction [ J ]. Thromb Haemost, 2000, 84(4) :204-209.
  • 9Ikata J, Wakatsuki T, Oishi Y, et al. Leukocytecounts and concentrati-ons and soluble asdhesion molecules aspredictors of coronary atherosclerosis [ J ]. Coron Artery Dis, 2000, 11(6) :445
  • 10Freedman J E, Loscalzo J. Platelet-monocyte aggregates: bridging thrombosis and inflammation[J]. Circulation, 2002, 105(18) :2130-2132.

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部